Skip to main content
. Author manuscript; available in PMC: 2010 May 1.
Published in final edited form as: Pain. 2009 Feb 23;143(1-2):65–70. doi: 10.1016/j.pain.2009.01.022

Table 4.

Clinical Factors Implicated in the Differential Diagnosis of OIH

Clinical factor Clinical finding
Temporal summation of second pain Exacerbated (QST)
Pain threshold (cold or heat) Decreased (QST) - particularly heat pain
Pain tolerance (cold or heat) Decreased (QST)
Supra-threshold stimulation Decreased duration of tolerance (QST)
Average opioid dose ≥ 75 mg daily morphine equivalent dose
Duration of opioid therapy ≥ 3 months
Opioid dose escalation Limited improvement or normalization on QST responses
Opioid dose reduction Improved opioid analgesia [38]
Pain quality Burning, diffuse pain, and spontaneous pain similar to those seen with neuropathic pain
Pain location At and/or beyond the dermatome distribution of a pre-existing pain condition
Pain intensity Similar or greater than pre-existing pain
Opioid type to be considered Short-acting vs. long acting; methadone versus other opioid analgesics
Gender Female vs. male?